References
- 1. Park CJ, Choi YJ, Kim JG, et al. Association of Acute Myocardial Infarction with ankylosing Spondylitis: A nationwide longitudinal cohort study. J Clin Neurosci. 2018;56:34-37. doi: 10.1016/j.jocn.2018.08.008.10.1016/j.jocn.2018.08.00830131197
- 2. Peters MJ, Visman I, Nielen MM, et al. Ankylosing spondylitis: a risk factor for myocardial infarction?. Ann Rheum Dis. 2010;69:579-581. doi: 10.1136/ard.2009.110593.10.1136/ard.2009.11059319403516
- 3. Mathieu S, Gossec L, Dougados M, Soubrier M. Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63:557-563. doi: 10.1002/acr.20364.10.1002/acr.2036420890982
- 4. Mathieu S, Pereira B, Soubrier M. Cardiovascular events in ankylosing spondylitis: an updated meta-analysis. Semin Arthritis Rheum. 2015;44:551-555. doi: 10.1016/j. semarthrit.2014.10.007.10.1016/j.semarthrit.2014.10.007
- 5. Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of coronary artery disease in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Transl Med. 2015;3:51. doi: 10.3978/j.issn.2305-5839.2015.02.05.
- 6. Christiansen MK. Early-onset Coronary Artery Disease Clinical and Hereditary Aspects. Dan Med J. 2017;64:B5406.
- 7. Khera AV, Kathiresan S. Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet. 2017;18:331-344. doi: 10.1038/nrg.2016.160.10.1038/nrg.2016.160593511928286336
- 8. Scheuner MT. Genetic evaluation for coronary artery disease. Genet Med. 2003;5:269-285. doi: 10.1097/01. GIM.0000079364.98247.26.10.1097/01
- 9. Maurovich-Horvat P, Tárnoki DL, Tárnoki ÁD, et al. Rationale, Design, and Methodological Aspects of the BUDAPEST-GLOBAL Study (Burden of Atherosclerotic Plaques Study in Twins-Genetic Loci and the Burden of Atherosclerotic Lesions). Clin Cardiol. 2015;38:699-707. doi: 10.1002/clc.22482.10.1002/clc.22482649083426492817